Princess Máxima Center and International Atomic Energy Agency join forces to improve radiotherapy treatments for children

Date:
1280×1280-internationaal_atoomenergieagentschap-6944110a32a7d

In the presence of Her Majesty Queen Máxima, representatives of the Princess Máxima Center and the International Atomic Energy Agency (IAEA) today signed a four-year partnership aimed at improving practical knowledge on the use of radiotherapy for children with cancer.

Worldwide, each year more than 400,000 children are diagnosed with cancer. For approximately 30% of patients, radiotherapy is an essential part of the overall treatment. This includes, among others, the treatment of brain tumors, leukemia, neuroblastoma, and rhabdomyosarcoma. Radiotherapy can help shrink a tumor prior to surgery or destroy remaining cancer cells after surgery and chemotherapy. In some brain tumors, surgery is not possible, and radiotherapy can be used as a primary treatment.

Collaborating Center

As part of the partnership, the IAEA has designated the Princess Máxima Center as an IAEA Collaborating Center for a period of four years to strengthen pediatric radiation oncology, medical physics and nutrition. Together, the Máxima Center and the IAEA will support international pediatric radiotherapy teams on enhancing their knowledge, skills and expertise through joint activities in education, training, quality improvement and research. 

‘It is our mission to reduce the big disparities in radiotherapy for children around the world; knowledge and training are a key part of that’, says Rafael Mariano Grossi, Director General of the IAEA. ‘I am very pleased that paediatric radiotherapy teams will be able to take what they have learned at the Princess Máxima Center back to colleagues in their home countries, and ultimately to the children and families who count on them.’    

Global disparities

International differences in radiotherapy have multiple causes. First, access to modern equipment is often limited. In addition, there is frequently insufficient training to treat children safely and effectively, with the lowest possible risk of late effects.   

‘We are grateful to the IAEA for giving us the opportunity to provide these radiotherapy oncologists the training that will help them treat children in their own countries more safely and effectively. In addition, it enables us to further advance our knowledge of childhood cancer by working more closely with hospitals in these regions’, says Prof. Dr. Rob Pieters, Chief Máxima International at the Princess Máxima Center. ‘In this way, it substantially contributes to our center’s mission which is shared by pediatric oncologists worldwide: curing every child with cancer, with the best possible quality of life. Everywhere.’

More news

News overview
UtrechtInc has been recognized in the Financial Times “Europe’s Leading Startup Hubs 2026” ranking.

UtrechtInc has been recognized in the Financial Times “Europe’s Leading Startup Hubs 2026” ranking.

While UtrechtInc is proud of this recognition, the real stars of the story are the entrepreneurs, researchers, and students who walk through its doors every day.

Hardloopsymposium

Are you participating in the Utrecht Marathon or are you a keen runner? Register for the Running Symposium on March 19th.

On Sunday, May 31st, Utrecht Science Park will once again be the setting for the Utrecht Marathon. Thousands of runners will line up at the starting line to achieve a fantastic feat: running a quarter, half, or full marathon! To help you prepare optimally, the Utrecht Science Park Foundation, in collaboration with partners Utrecht University, UMC Utrecht, Utrecht University of Applied Sciences, and Olympos Sports Centre, is organizing a running symposium where you’ll be informed and inspired to get the most out of your running performance.

utrechtinc validation program

Applications Now Open for UtrechtInc Validation Programmes

Have you ever wondered what it takes to turn research or an idea into a startup? The validation programmes offered by UtrechtInc may provide the first step. Applications are now open.

Utrecht Science Park researchers receive prestigious Cancer Grand Challenge grants

Several research groups, including researchers from UMC Utrecht, the Princess Máxima Center, and the Hubrecht Institute, have been selected for a prestigious Cancer Grand Challenge (CGC) grant. Cancer Grand Challenges was co-founded in 2020 by Cancer Research UK and the National Cancer Institute in the United States. The initiative supports international, multidisciplinary research teams focusing on major challenges in cancer research.